Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.8 EUR
27.84 M EUR
629.99 M EUR
17.79 M
About MOCHIDA PHARMACEUTICAL CO
Sector
Headquarters
Tokyo
Founded
1913
Website
ISIN
JP3922800002
FIGI
BBG000C4SM44
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. It operates through following business divisions: Pharmaceuticals and Healthcare Products. The Pharmaceuticals division conducts research and development for medical needs. The Healthcare Products division manufactures and sells cosmetic and medicated products. It also manufactures and sells prescription drugs for cardiovascular, obstetrics and gynecology, dermatology, emergency and psychiatric ailments. The company was founded by Ryokichi Mochida in February 1913 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MFY is 20.0 EUR — it has increased by 0.50% in the past 24 hours. Watch MOCHIDA PHARM. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MOCHIDA PHARM. stocks are traded under the ticker MFY.
MFY stock has risen by 1.01% compared to the previous week, the month change is a −2.91% fall, over the last year MOCHIDA PHARM. has showed a 1.01% increase.
MFY stock is 0.50% volatile and has beta coefficient of 0.49. Track MOCHIDA PHARM. stock price on the chart and check out the list of the most volatile stocks — is MOCHIDA PHARM. there?
Today MOCHIDA PHARM. has the market capitalization of 725.87 M, it has increased by 0.27% over the last week.
Yes, you can track MOCHIDA PHARM. financials in yearly and quarterly reports right on TradingView.
MOCHIDA PHARM. is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
MFY net income for the last quarter is 7.94 M EUR, while the quarter before that showed 9.01 M EUR of net income which accounts for −11.88% change. Track more MOCHIDA PHARM. financial stats to get the full picture.
MOCHIDA PHARM. dividend yield was 2.48% in 2023, and payout ratio reached 63.10%. The year before the numbers were 2.40% and 44.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 1.52 K employees. See our rating of the largest employees — is MOCHIDA PHARM. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOCHIDA PHARM. EBITDA is 53.36 M EUR, and current EBITDA margin is 8.37%. See more stats in MOCHIDA PHARM. financial statements.
Like other stocks, MFY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOCHIDA PHARM. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOCHIDA PHARM. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOCHIDA PHARM. stock shows the sell signal. See more of MOCHIDA PHARM. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.